Piao Wenji, Ru Lisa W, Toshchakov Vladimir Y
Department of Microbiology and Immunology, University of Maryland School of Medicine, 685 West Baltimore St., HSFI, Baltimore, MD 21201, USA.
Department of Microbiology and Immunology, University of Maryland School of Medicine, 685 West Baltimore St., HSFI, Baltimore, MD 21201, USA
Pathog Dis. 2016 Jul;74(5). doi: 10.1093/femspd/ftw043. Epub 2016 May 4.
TLR2 heterodimers with TLR1 or TLR6 recognize distinct pathogen-associated molecules such as tri- and di-acylated lipopeptides. The activated TLR2 heterodimers recruit Toll-IL-1R domain- (TIR-) containing adapter proteins, TIRAP and MyD88, through the receptor TIR domains. Molecular recognition mechanisms responsible for agonist-driven, TIR domain-mediated receptor-adapter interactions as well as the structure of resultant signaling complexes remain unknown. We previously reported that the cell-permeable peptide derived from helix D of TLR2 TIR (2R9) specifically binds TIRAP in vitro and in cells and thereby inhibits TIRAP-dependent TLR signaling. This study demonstrates that cell-permeable peptides from D helix of TLR1 or TLR6, peptides 1R9 and 6R9 respectively, inhibit signaling mediated by cognate TLR2 co-receptors. Interestingly, 1R9 and 6R9 bind different TLR2 adapters, as they selectively bind MyD88 and TIRAP TIR, respectively. Both peptides block the agonist-induced co-immunoprecipitation (co-IP) of TLR2 with TIRAP or MyD88, but not TLR2 co-IP with co-receptors. Our data suggest that D helices of TLR1 and TLR6 TIR domains are adapter recruitment sites in both co-receptors; yet the sites recruit different adapters. The D helix in TLR1 is the MyD88 docking site, whereas in TLR6 this site recruits TIRAP.
TLR2与TLR1或TLR6形成的异二聚体可识别不同的病原体相关分子,如三酰化和二酰化脂肽。活化的TLR2异二聚体通过受体TIR结构域招募含Toll-IL-1R结构域(TIR)的接头蛋白TIRAP和MyD88。负责激动剂驱动的、TIR结构域介导的受体-接头相互作用的分子识别机制以及由此产生的信号复合物的结构仍然未知。我们之前报道过,源自TLR2 TIR螺旋D的细胞穿透肽(2R9)在体外和细胞内特异性结合TIRAP,从而抑制TIRAP依赖的TLR信号传导。本研究表明,分别来自TLR1或TLR6 D螺旋的细胞穿透肽,即肽1R9和6R9,可抑制同源TLR2共受体介导的信号传导。有趣的是,1R9和6R9结合不同的TLR2接头蛋白,因为它们分别选择性地结合MyD88和TIRAP的TIR。这两种肽均阻断激动剂诱导的TLR2与TIRAP或MyD88的共免疫沉淀(co-IP),但不阻断TLR2与共受体的co-IP。我们的数据表明,TLR1和TLR6 TIR结构域的D螺旋是两种共受体中的接头蛋白招募位点;然而,这些位点招募不同的接头蛋白。TLR1中的D螺旋是MyD88对接位点,而在TLR6中该位点招募TIRAP。